East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Furosemide Tablets USP, 20 mg, 40 mg, and 80 mg. Aurobindo Pharma’s Furosemide Tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), Lasix Tablets manufactured by Validus Pharmaceuticals LLC.

Furosemide Tablets are indicated in:

• Adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome.
• May be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents.